Medications

Nasal antiviral blocks SARS-CoV-2 infection in mice

SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed ...

Medications

Antibody shows promise for developing hantavirus treatment

An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine. Based ...

Diseases, Conditions, Syndromes

Efficacy of COVID-19 vaccines against omicron studied

There is virtually no protection against infection with the currently circulating omicron variant of the SARS-CoV-2 virus for dual-vaccinated and recovered individuals who were infected with the previous SARS-CoV-2 variants. ...

Medications

US authorizes new antibody drug to fight omicron

U.S. health regulators on Friday authorized a new antibody drug that targets the omicron variant, a key step in restocking the nation's arsenal against the latest version of COVID-19.

Diseases, Conditions, Syndromes

Video: Researcher discusses drug resistance in COVID-19

Yang Wang, MD, Ph.D., professor of medicine and deputy director of product discovery at MassBiologics of UMass Chan Medical School, leads a team of scientists working to discover and develop antibody-based medicines for infectious ...

page 6 from 34